- Home
- NEGG vs ANGO Comparison
NEGG vs ANGO Comparison
Compare NEGG & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEGG | ANGO |
|---|---|---|
| Founded | 2001 | 1988 |
| Country | United States | United States |
| Employees | 762 | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.1M | 439.8M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | NEGG | ANGO |
|---|---|---|
| Price | $37.75 | $10.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 43.1K | ★ 329.2K |
| Earning Date | 04-27-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.11 |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $0.21 | $8.36 |
| 52 Week High | $137.84 | $13.99 |
Technical Indicators
Market Signals| Indicator | NEGG | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 44.00 | 43.56 |
| Support Level | $30.58 | $10.38 |
| Resistance Level | $56.73 | $11.06 |
| Average True Range (ATR) | 3.97 | 0.49 |
| MACD | 0.28 | 0.04 |
| Stochastic Oscillator | 41.43 | 6.60 |
Price Performance
Historical ComparisonAbout NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.